Intercure Ltd. (INCR) stock
INCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 3/30
$3.61−0.02 (-0.55%)
Close on Nov 17, 2026Market cap $197.40MP/E –Yield –
Intercure price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Intercure's price to sales ratio was 2.3× on Nov 10, 2026, against 4.2× a year earlier. Over the last 5 years it ranged from 2.3× to 40.9×, with a median of 4.6×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 10, 2026 | 2.3× | −0.5 |
| 2025 | Dec 31, 2025 | 2.8× | −0.9 |
| 2024 | Dec 31, 2024 | 3.7× | +1.0 |
| 2023 | Dec 29, 2023 | 2.7× | −7.5 |
| 2022 | Dec 30, 2022 | 10.2× | −29.1 |
| 2021 | Dec 31, 2021 | 39.3× | −15.3 |
| 2020 | Dec 31, 2020 | 54.5× | – |
See a number that looks wrong?